Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Podcast Episode Summary

Introduction

Dr. Warrick Bishop, a cardiologist, author, and CEO of the Healthy Heart Network, hosts this episode to educate listeners about cardiovascular health and disease prevention. In this episode, Dr. Bishop shares five major highlights from the European Society of Cardiology Congress held in Amsterdam in August, presenting recent research findings that are changing clinical practice in cardiology. The episode emphasizes how understanding these advances can help patients live healthier lives and potentially prevent heart disease.

Key Takeaways:

• Complete revascularization during acute coronary syndrome intervention in older patients (average age 80) reduces death, further heart attacks, stroke, and future revascularization procedures, not just treating the primary culprit artery.

• A large trial showed iron infusion therapy (ferric carboxymaltose) did not benefit heart failure patients with reduced ejection fraction, contradicting previous evidence, though further research is needed before changing current practice.

• Atrial fibrillation ablation is more effective in end-stage heart failure patients, highlighting the importance of maintaining normal sinus rhythm rather than atrial fibrillation in cardiac patients.

• New ESC cardiomyopathy guidelines, led by Australian researchers, emphasize a multidisciplinary approach integrating cardiologists, geneticists, genetic counselors, pathologists, and general practitioners to manage genetic heart disease.

• GLP-1 receptor agonists (such as Ozempic and Wegovy) significantly benefit obese patients with heart failure with preserved ejection fraction, producing 10-15% weight loss and improving functional capacity like six-minute walking distance.

• Weight loss in heart failure patients with preserved ejection fraction improves symptoms and quality of life regardless of underlying cardiac issues, making weight management a critical intervention.

• Genetic testing and screening advances are allowing better identification of individuals with genetic predisposition to cardiac disease and enabling family screening.